At least twice as many patients on the approved spesolimab dose maintain improvement in skin symptoms and quality of life ...

German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised pustular psoriasis (GPP), in ...

Other potential disease targets include palmoplantar pustulosis, generalised pustular psoriasis and pyoderma gangrenosum. Several further phase 2 trials are planned soon, the company said.

LEO Pharma A/S, a global leader in medical dermatology, today announced the initiation of the phase 2a proof-of-concept DELTA NEXT trial. The trial aims to evaluate the efficacy and safety of ...

May 27, 2025 — Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than total body fat, particularly in women. This link ...

If topical medications haven’t been strong enough to control your psoriasis, your dermatologist may recommend a biologic, a type of drug that targets the part of the immune system responsible ...

1998; Helwig, 2000; Stein, 2000). Psoriasis affects 2% of the U.S. population, accounting for 10% of outpatient visits to dermatologists (Thompson, Feldman, & Fleischer, 1998). In a university ...

Psoriasis attacks healthy cells, causing inflammation that leads to plaques and other skin changes. Some of the same underlying triggers that drive psoriasis may also pose problems for your heart ...

However, they are sometimes signs of a condition requiring treatment, such as psoriasis, contact dermatitis, or head lice. Treatment options for scalp sores or scabs depend on the cause but ...

Generalized pustular psoriasis may be difficult to manage, but treatments such as biologics may help reduce symptoms and the likelihood of serious… READ MORE Is Taltz an Immunosuppressant Drug?

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.